Identification of proteins involved in microglial endocytosis of alpha-synuclein.
Aggregated alpha-synuclein, a protein playing pivotal roles in the pathogenesis of Parkinson disease (PD) and related synucleinopathy, has been shown to activate microglia, the key cells in neuroinflammation. However, the mechanisms by which aggregated alpha-synuclein enters microglia remain uncharacterized. In this study, we first replicated our previous results with a modified protocol that generated aggregated alpha-synuclein more efficiently. Next, using two recently developed proteomic techniques, SILAC (Stable Isotope Labeling of Amino acid in Cell cultures) and PROCEED (PROteome of Cell Exposed Extracellular Domains), we studied the plasma membrane proteins of primary cultured microglia that might be interacting with aggregated alpha-synuclein and mediating its internalization. The results demonstrated that 250 nM alpha-synuclein, aged for 6 h with a magnetic stir bar, was just as potent in activating microglia as the aggregated alpha-synuclein produced by aging without constant agitation for 7 days. The proteomic analysis identified 111 membrane proteins; of these, 46 proteins were altered in relative abundance in the membrane compartment after treatment with aggregated alpha-synuclein for 3 h. Two of these proteins, clathrin and calnexin, were further evaluated with Western blotting, demonstrating good agreement with quantitative proteomics. Finally, immunocytochemical as well as co-immunoprecipitation studies indicated that clathrin was indeed co-localized with internalized alpha-synuclein in microglia. These results suggest for the first time that microglial activation secondary to internalization of aggregated alpha-synuclein likely requires participation of clathrin, which is an essential protein of the polyhedral coat of coated pits and vesicles that play major roles in endocytosis and vesicular trafficking.
Liu
Jun
J
Departments of Pathology and Materials Science & Engineering, University of Washington School of Medicine, Seattle, Washington 98104, USA.
Zhou
Yong
Y
Wang
Yan
Y
Fong
Hanson
H
Murray
Thomas M
TM
Zhang
Jing
J
D000818:Animals; D001921:Brain / Q000378:metabolism; D037281:Calnexin / Q000737:chemistry; D002462:Cell Membrane / Q000378:metabolism; D002966:Clathrin / Q000737:chemistry / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D004705:Endocytosis; D006863:Hydrogen-Ion Concentration; D017628:Microglia / Q000378:metabolism; D010300:Parkinson Disease / Q000378:metabolism; D011506:Proteins / Q000737:chemistry; D040901:Proteomics / Q000379:methods; D051381:Rats; D017207:Rats, Sprague-Dawley; D051844:alpha-Synuclein / Q000737:chemistry*
D002966:Clathrin; D011506:Proteins; D051844:alpha-Synuclein; D037281:Calnexin; D015232:Dinoprostone